NCT05474183View on ClinicalTrials.gov

The Role of Ketamine and Dexmedetomidine in Opioid-Sparing Analgesia

NACompletedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

August 5, 2022

Primary Completion Date

May 10, 2023

Study Completion Date

May 20, 2023

Conditions

Ketamine-Induced Mood Disorder

Interventions

DRUG

Ketamine

drug

Trial Locations (1)

63514

Fayoum University hospital, Al Fayyum

All Listed Sponsors

lead

Fayoum University Hospital

OTHER